Literature DB >> 17001206

ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.

Asterios Deligiannis1, Hans Björnstad, Francois Carre, Hein Heidbüchel, Evangelia Kouidi, Nicole M Panhuyzen-Goedkoop, Fabio Pigozzi, Wilhelm Schänzer, Luc Vanhees.   

Abstract

The use of doping substances and methods is extensive not only among elite athletes, but also among amateur and recreational athletes. Many types of drugs are used by athletes to enhance performance, to reduce anxiety, to increase muscle mass, to reduce weight or to mask the use of other drugs during testing. However, the abuse of doping substances and methods has been associated with the occurrence of numerous health side-effects. The adverse effects depend on the type of the consumed drug, as well as the amount and duration of intake and the sensitivity of the body, since there is a large inter-individual variability in responses to a drug. Usually the doses used in sports are much higher than those used for therapeutic purposes and the use of several drugs in combination is frequent, leading to higher risk of side-effects. Among biomedical side-effects of doping, the cardiovascular ones are the most deleterious. Myocardial infarction, hyperlipidemia, hypertension, thrombosis, arrythmogenesis, heart failure and sudden cardiac death have been noted following drug abuse. This paper reviews the literature on the adverse cardiovascular effects after abuse of prohibited substances and methods in athletes, aiming to inform physicians, trainers and athletes and to discourage individuals from using drugs during sports.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001206     DOI: 10.1097/01.hjr.0000224482.95597.7a

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  18 in total

Review 1.  Blood flow restriction training and the exercise pressor reflex: a call for concern.

Authors:  Marty D Spranger; Abhinav C Krishnan; Phillip D Levy; Donal S O'Leary; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-04       Impact factor: 4.733

Review 2.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

3.  Periodical cardiovascular screening is mandatory for elite athletes.

Authors:  H Inklaar; N M Panhuyzen-Goedkoop
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

Review 4.  [Sports cardiology : Overview of relevant clinical topics].

Authors:  R Laszlo; J Scharhag; C Burgstahler; H Striegel; J M Steinacker
Journal:  Herz       Date:  2017-01-23       Impact factor: 1.443

Review 5.  Considerations in the Use of Stimulants in Sport.

Authors:  Claudia L Reardon; Robert M Factor
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

6.  Clenbuterol-Induced Myocarditis: A Case Report.

Authors:  Natassja Moriarty; Nadeem Attar
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-24

7.  Hyperhomocysteinemia in winter elite athletes: a longitudinal study.

Authors:  P Borrione; F Pigozzi; G Massazza; H Schonhuber; G Viberti; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

8.  The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective.

Authors:  Annie A Garner; Ashley A Hansen; Catherine Baxley; Michael J Ross
Journal:  Sports Med       Date:  2018-03       Impact factor: 11.136

9.  Smoking and Vaping in Amateur Rugby Players, Coaches and Referees: Findings from a Regional Survey Might Help to Define Prevention Targets.

Authors:  Frédéric Chagué; Emmanuel Reboursière; Jean Israël; Jean-Philippe Hager; Patrice Ngassa; Marc Geneste; Jean-Pierre Guinoiseau; Gilles Garet; Jacques Girardin; Jacques Sarda; Yves Cottin; Marianne Zeller
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390

10.  Early Left Ventricular Diastolic Dysfunction, Reduced Baroreflex Sensitivity, and Cardiac Autonomic Imbalance in Anabolic-Androgenic Steroid Users.

Authors:  Evangelia Joseph Kouidi; Antonia Kaltsatou; Maria Apostolos Anifanti; Asterios Pantazis Deligiannis
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.